Compare Ascendis Pharma A/S (ASND) vs Credo Technology Group Holding Ltd (CRDO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Credo Technology Group Holding Ltd — how do they compare? Ascendis Pharma A/S trades at $254.5 (market cap $16.67B), while Credo Technology Group Holding Ltd trades at $260.39 (market cap $46.19B). The key difference: Credo Technology Group Holding Ltd is far larger — about 2.8× Ascendis Pharma A/S's market cap. Which is the better fit depends on your goals.
| ASND | CRDO | |
|---|---|---|
Market Cap | $16.67B | $46.19B |
Sector | Health | Technology |
52-Week High | $277.18 | $302.52 |
52-Week Low | $189.74 | $87.81 |
Enterprise Value | $17.04B | $44.77B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Credo Technology Group Holding Ltd
Credo Technology provides high-speed connectivity solutions for AI-driven applications and hyperscale data centers. Its products enable faster, more energy-efficient data transmission for cloud and telecom infrastructure.
Read more on CRDO →
